Highlights and a hidden hazard--the FDA's new labeling regulations.
暂无分享,去创建一个
The FDA is trying to make the official descriptions of prescription drugs — which are notoriously user-hostile — more helpful. Drs. Jerry Avorn and William Shrank write that the most troubling aspect of the FDA's new plan has nothing to do with providing information to prescribers.
[1] Nidhi R. Shah,et al. Adherence to black box warnings for prescription medications in outpatients. , 2006, Archives of internal medicine.